Abbott India has informed that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024, to consider and approve the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2023. In terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company remains closed from Monday, January 1, 2024 to Saturday, February 3, 2024.
The above information is a part of company’s filings submitted to BSE.
